| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Patient Officer | EVP,Corporate &Medical Affairs +1 more
2 companies
Alton Gregg H is a Chief Patient Officer at GILEAD SCIENCES, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $7.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 15,000 | $75.88 | $1,138,189.50 | -14.1% | |
| Jul 21, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sale+OE | 40,000 | $74.00 | $2,960,000.00 | -16.6% | |
| Jul 3, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sell | 5,000 | $71.06 | $355,295.00 | -4.6% | |
| Jun 1, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sell | 5,000 | $65.02 | $325,113.50 | -4.4% | |
| May 1, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sell | 5,000 | $68.31 | $341,529.00 | -4.2% | |
| Mar 30, 2017 | GILD Gilead Sciences, Inc. | EVP Comm&Acs Ala, Corp&Med Aff | Sell | 5,000 | $67.48 | $337,392.00 | -4.1% |